arrow
S

Shuichi Aoki

Tohoku University
H指数:20
被引数:1,898

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Utility of longitudinal changes in CA19-9 for detection of pancreatic ductal adenocarcinoma in patients with benign pancreatic diseases

良性胰腺疾病患者中CA19-9纵向变化在胰腺导管腺癌检测中的效用

2026-10-070
PRE
Correction: Molecular insights into HER2/ERBB2 amplification and carcinogenesis in gallbladder cancer associated with pancreaticobiliary maljunction

更正:HER2/ERBB2扩增及与胰胆管合流异常相关的胆囊癌的分子机制

2025-11-260
OAAI
Molecular insights into HER2/ERBB2 amplification and carcinogenesis in gallbladder cancer associated with pancreaticobiliary maljunction

胆囊癌中HER2/ERBB2扩增与致癌作用的分子机制研究

2025-10-040
OA
Local Recurrence and Survival Outcomes After Portal Vein/Superior Mesenteric Vein Separation Without Resection Preceding Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma

胰管腺癌新辅助治疗前未行切除的肠系膜上静脉/门静脉分离术后局部复发与生存结局

2025-10-011
PRE
Frey procedure for chronic pancreatitis improves bile duct stricture

Frey procedure for chronic pancreatitis improves bile duct stricture

2025-10-010
OAAI
Clonal analysis of metachronous double biliary tract cancers

异时性双胆道癌的克隆分析

2024-03-141
OA
Dendritic cell paucity in mismatch repair-proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy

错配修复熟练的结直肠癌肝转移中树突状细胞的缺乏限制了免疫检查点阻断的疗效

2021-11-0142
OAAI
Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma

Regorafenib联合PD1阻断通过诱导CXCL10表达增加肝癌CD8 T细胞浸润

2020-11-2499
OAAI
Antibody-mediated delivery of viral epitopes to tumors harnesses CMV-specific T cells for cancer therapy
2020-02-1054
OAAI
Dual Programmed Death Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma
2019-10-14297
OAAI
Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients

新辅助治疗后血清糖类抗原19-9水平降低预示胰腺癌患者预后较好: 240例患者的多中心病例对照研究

2019-03-2177
OAAI